{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T13:48:56Z","timestamp":1794404936230,"version":"4.9.0"},"reference-count":83,"publisher":"SAGE Publications","issue":"3_suppl","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"EU H2020"},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020400","name":"John Black Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020400","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000304","name":"Parkinson's UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000304","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["228306\/Z\/23\/Z"],"award-info":[{"award-number":["228306\/Z\/23\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008487","name":"Cure Parkinson's Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008487","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EU FP7"},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Parkinson\u2019s Disease"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:p>Parkinson's disease (PD) is a common neurodegenerative disorder associated with the accumulation of alpha-synuclein in Lewy bodies and Lewy neurites, as well as cell loss, including ventral midbrain dopaminergic (vmDA) neurons in the substantia nigra. This degeneration is responsible for some of the characteristic motor features of PD, which, in the early stages of the disease, can be successfully treated pharmacologically. However, in later stages of the disease, the efficacy of these drugs declines, and they can cause side effects. Dopamine cell therapy, which involves replacing lost vmDA neurons by implanting new exogenous ones, is a promising alternative. While research on dopamine cell therapies has made substantial progress over the last few decades, from early foetal transplants to stem cell-derived transplants currently in clinical trials, it is also susceptible to potential misconceptions. This review summarises the past, present, and future of this therapeutic strategy whilst also discussing these potential misconceptions. In doing so, the status of dopamine cell therapy for PD will be critically summarised.<\/jats:p>","DOI":"10.1177\/1877718x261434672","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T13:51:06Z","timestamp":1776433866000},"page":"5-16","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Stem cell treatments and Parkinson's disease: Science and misconceptions"],"prefix":"10.1177","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2663-8729","authenticated-orcid":false,"given":"Athena","family":"Stamper","sequence":"first","affiliation":[{"name":"Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Bulstrode","sequence":"additional","affiliation":[{"name":"Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8843-7730","authenticated-orcid":false,"given":"Roger A","family":"Barker","sequence":"additional","affiliation":[{"name":"Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK"},{"name":"Department of Clinical Neurosciences, John van Geest Centre for Brain Repair, University of Cambridge, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1176\/jnp.14.2.223"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/42166"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.13"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(80)90692-7"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/289497a0"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(79)90472-4"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.571147"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00271860"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1989.00520420033021"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2105529"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/123.7.1380"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410350208"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410420115"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199211263272202"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410380307"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2000.92.5.0863"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2002.96.3.0589"},{"key":"e_1_3_3_19_2","first-page":"325","article-title":"Cellular replacement of dopamine deficit in Parkinson\u2019s disease using human fetal mesencephalic tissue: preliminary results in four patients","volume":"71","author":"Redmond DE","year":"1993","unstructured":"Redmond DE, Robbins RJ, Naftolin F, et al. Cellular replacement of dopamine deficit in Parkinson\u2019s disease using human fetal mesencephalic tissue: preliminary results in four patients. Res Publ Assoc Res Nerv Ment Dis 1993; 71: 325\u2013359.","journal-title":"Res Publ Assoc Res Nerv Ment Dis"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199211263272203"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200103083441002"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10720"},{"key":"e_1_3_3_23_2","first-page":"1","article-title":"Serotonergic neurons mediate dyskinesia side effects in Parkinson\u2019s patients with neural transplants","volume":"2","author":"Politis M","unstructured":"Politis M, Wu K, Loane C, et al. Serotonergic neurons mediate dyskinesia side effects in Parkinson\u2019s patients with neural transplants. Sci Transl Med 2010 June 30; 2: 1\u20137.","journal-title":"Sci Transl Med"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23743"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1747"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1746"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1605245113"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1752"},{"key":"e_1_3_3_29_2","first-page":"956","article-title":"Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson\u2019s disease","volume":"345","author":"Deep-Brain Stimulation for Parkinson\u2019s Disease Study Group","unstructured":"Deep-Brain Stimulation for Parkinson\u2019s Disease Study Group. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson\u2019s disease. N Engl J Med 2001 Sep 27; 345: 956\u2013963.","journal-title":"N Engl J Med"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70295-8"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0507-2"},{"key":"e_1_3_3_32_2","first-page":"1","article-title":"The TransEuro open-label trial of human fetal ventral mesencephalic transplantation in patients with moderate Parkinson\u2019s disease","volume":"44","author":"Barker RA","unstructured":"Barker RA, Lao-Kaim NP, Guzman NV, et al. The TransEuro open-label trial of human fetal ventral mesencephalic transplantation in patients with moderate Parkinson\u2019s disease. Nat Biotechnol 2025 May; 44: 1\u20139.","journal-title":"Nat Biotechnol"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1201-1129"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1634\/stemcells.2005-0393"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1010209107"},{"key":"e_1_3_3_36_2","first-page":"1265","article-title":"In vitro and in vivo analyses of human embryonic stem cell-derived dopamine neurons","volume":"92","author":"Park CH","year":"2005","unstructured":"Park CH, Minn YK, Lee JY, et al. In vitro and in vivo analyses of human embryonic stem cell-derived dopamine neurons. JNC 2005; 92: 1265\u20131276.","journal-title":"JNC"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0404700101"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1634\/stemcells.2006-0380"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1634\/stemcells.2008-0039"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1634\/stemcells.22-6-925"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1495"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/glia.20654"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1242\/dev.02879"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature10648"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2012.04.009"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2016.09.004"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2014.01.013"},{"key":"e_1_3_3_48_2","first-page":"1","article-title":"Purification of functional human ES and iPSC-derived midbrain dopaminergic progenitors using LRTM1","volume":"7","author":"Samata B","unstructured":"Samata B, Doi D, Nishimura K, et al. Purification of functional human ES and iPSC-derived midbrain dopaminergic progenitors using LRTM1. Nat Commun 2016 Oct 14; 7: 1\u201311.","journal-title":"Nat Commun"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2017.08.016"},{"key":"e_1_3_3_50_2","first-page":"337","article-title":"Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson\u2019s disease","volume":"11","author":"Doi D","unstructured":"Doi D, Magotani H, Kikuchi T, et al. Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson\u2019s disease. Nat Commun 2020 July 6; 11: 337\u2013350.","journal-title":"Nat Commun"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2021.01.005"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2017.078"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2023.11.009"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2021.01.004"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2024.12.005"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2023.08.014"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1915872"},{"key":"e_1_3_3_58_2","first-page":"1","article-title":"Phase I\/II trial of iPS-cell-derived dopaminergic cells for Parkinson\u2019s disease","volume":"641","author":"Sawamoto N","unstructured":"Sawamoto N, Doi D, Nakanishi E, et al. Phase I\/II trial of iPS-cell-derived dopaminergic cells for Parkinson\u2019s disease. Nature 2025 Apr 16; 641: 1\u20137.","journal-title":"Nature"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-008-0352-8"},{"key":"e_1_3_3_60_2","first-page":"1","article-title":"Phase I trial of hES cell-derived dopaminergic neurons for Parkinson\u2019s disease","volume":"16","author":"Tabar V","unstructured":"Tabar V, Sarva H, Lozano AM, et al. Phase I trial of hES cell-derived dopaminergic neurons for Parkinson\u2019s disease. Nature 2025 Apr ; 16: 1\u20136.","journal-title":"Nature"},{"key":"e_1_3_3_61_2","first-page":"1","article-title":"Phase 1\/2a clinical trial of hESC-derived dopamine progenitors in Parkinson\u2019s disease","volume":"188","author":"Chang JW","unstructured":"Chang JW, Na HK, Chang KW, et al. Phase 1\/2a clinical trial of hESC-derived dopamine progenitors in Parkinson\u2019s disease. Cell 2025 Dec 11; 188: 1\u201313.","journal-title":"Cell"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaf322"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-230328"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-019-0180-6"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2020.01.010"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.05.030"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2025.07.012"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.2217\/rme-2016-0057"},{"key":"e_1_3_3_69_2","first-page":"1","article-title":"MHC Matching improves engraftment of iPSC-derived neurons in non-human primates","volume":"8","author":"Morizane A","unstructured":"Morizane A, Kikuchi T, Hayashi T, et al. MHC Matching improves engraftment of iPSC-derived neurons in non-human primates. Nat Commun 2017 Aug; 8: 1\u201312.","journal-title":"Nat Commun"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67813-0"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0016-3"},{"key":"e_1_3_3_72_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-023-01784-x"},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2503822"},{"key":"e_1_3_3_74_2","first-page":"1","article-title":"Role of CD47 in tumor immunity: a potential target for combination therapy","volume":"12","author":"Huang J","unstructured":"Huang J, Liu F, Li C, et al. Role of CD47 in tumor immunity: a potential target for combination therapy. Sci Rep 2022 June 13; 12: 1\u201311.","journal-title":"Sci Rep"},{"key":"e_1_3_3_75_2","first-page":"1","article-title":"Human stem cells harboring a suicide gene improve the safety and standardisation of neural transplants in parkinsonian rats","volume":"12","author":"de Luzy IR","unstructured":"de Luzy IR, Law KCL, Moriarty N, et al. Human stem cells harboring a suicide gene improve the safety and standardisation of neural transplants in parkinsonian rats. Nat Commun 2021 May 27; 12: 1\u201311.","journal-title":"Nat Commun"},{"key":"e_1_3_3_76_2","first-page":"1","article-title":"The morphological and molecular changes of brain cells exposed to direct current electric field stimulation","volume":"18","author":"Pelletier SJ","unstructured":"Pelletier SJ, Lagac\u00e9 M, St-Amour I, et al. The morphological and molecular changes of brain cells exposed to direct current electric field stimulation. Int J Neuropsychopharmacol 2015 Mar 1; 18: 1\u201316.","journal-title":"Int J Neuropsychopharmacol"},{"key":"e_1_3_3_77_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0700293104"},{"key":"e_1_3_3_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2009.06.014"},{"key":"e_1_3_3_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2016.04.017"},{"key":"e_1_3_3_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2016.03.014"},{"key":"e_1_3_3_81_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI74664"},{"key":"e_1_3_3_82_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-024-03921-y"},{"key":"e_1_3_3_83_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1279-16.2016"},{"key":"e_1_3_3_84_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awae026"}],"container-title":["Journal of Parkinson\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X261434672","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1877718X261434672","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X261434672","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T13:14:23Z","timestamp":1794402863000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1877718X261434672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":83,"journal-issue":{"issue":"3_suppl","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10.1177\/1877718X261434672"],"URL":"https:\/\/doi.org\/10.1177\/1877718x261434672","relation":{},"ISSN":["1877-7171","1877-718X"],"issn-type":[{"value":"1877-7171","type":"print"},{"value":"1877-718X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]}}}